/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at $52.3 billion by market cap, Becton, Dickinson and Company (BDX) is a leading medical technology company headquartered in Franklin Lakes, New Jersey. Founded in 1897, BD develops, manufactures, and sells a wide range of medical devices, laboratory equipment, and diagnostic products that improve the safety, efficiency, and quality of healthcare worldwide.
The medical technology titan is expected to announce its fiscal fourth-quarter earnings for 2025 before the market opens on Thursday, Nov. 6. Ahead of the event, analysts expect BDX to report a profit of $3.91 per share on a diluted basis, down 2.6% from $3.81 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.